Subcellular Technology Lab., N.N. Petrov National Medical Research Center of Oncology, 195251 St. Petersburg, Russia.
Oncosystem Ltd., 121205 Moscow, Russia.
Cells. 2020 Aug 18;9(8):1917. doi: 10.3390/cells9081917.
The current approaches to distinguish follicular adenomas (FA) and follicular thyroid cancer (FTC) at the pre-operative stage have low predictive value. Liquid biopsy-based analysis of circulating extracellular vesicles (EVs) presents a promising diagnostic method. However, the extreme heterogeneity of plasma EV population hampers the development of new diagnostic tests. We hypothesize that the isolation of EVs with thyroid-specific surface molecules followed by miRNA analysis, may have improved diagnostic potency.
The total population of EVs was isolated from the plasma of patients with FA ( = 30) and FTC ( = 30). Thyroid peroxidase (TPO)-positive EVs were isolated from the total populations using immune-beads. The miRNA from the TPO(+)EVs obtained from the plasma of FA and FTC patients was assayed by RT-PCR. The diagnostic potency of the selected miRNAs was estimated by the receiver operating characteristic (ROC) analysis.
TPO(+)EVs can be efficiently isolated by immunobeads. The analysis of Let-7 family members in TPO(+)EVs allows one to distinguish FA and FTC with high accuracy (area under curve defined by ROC = 0.77-0.84).
The isolation of TPO(+)EVs, followed by RT-qPCR analysis of Let-7 family members, may present a helpful approach to manage follicular nodules in the thyroid gland.
目前在术前阶段区分滤泡性腺瘤(FA)和滤泡性甲状腺癌(FTC)的方法预测价值较低。基于液体活检的循环细胞外囊泡(EVs)分析提供了一种很有前途的诊断方法。然而,血浆 EV 群体的极端异质性阻碍了新诊断测试的发展。我们假设,使用甲状腺特异性表面分子分离 EVs 并进行 miRNA 分析,可能会提高诊断效力。
从 FA(n=30)和 FTC(n=30)患者的血浆中分离总 EV 群体。使用免疫珠从总群体中分离甲状腺过氧化物酶(TPO)阳性 EVs。使用 RT-PCR 测定从 FA 和 FTC 患者血浆中获得的 TPO(+)EVs 的 miRNA。通过接收者操作特征(ROC)分析估计选定 miRNA 的诊断效力。
TPO(+)EVs 可通过免疫珠高效分离。TPO(+)EVs 中 Let-7 家族成员的分析可以高精度区分 FA 和 FTC(ROC 定义的曲线下面积为 0.77-0.84)。
TPO(+)EV 的分离,以及随后对 Let-7 家族成员的 RT-qPCR 分析,可能为甲状腺滤泡结节的管理提供一种有用的方法。